Analyze Diet
Journal of biological standardization1983; 11(3); 227-240; doi: 10.1016/s0092-1157(83)80010-9

A collaborative assay of mycoplasma reference antisera.

Abstract: A total of 29 Mycoplasma and Acholeplasma antiserum reagents produced in mules and horses by the Baltimore Biological Laboratory and by Huntingdon Research Centre, under the auspices of National Institutes of Health, Bethesda, USA, were tested for potency and specificity, by a great variety of serological techniques, at the FAO/WHO Collaborating centre for Animal Mycoplasmas, University of Aarhus, Denmark. Subsequently, the antisera were subjected to a collaborative assay in which 20 workers from 15 different laboratories participated under the auspices of the International Research Programme on Comparative Mycoplasmology, International Organization for Mycoplasmology (IOM). Each antiserum was tested for homologous and heterologous reactivity by the growth inhibition (GI) and metabolism inhibition (MI) tests in at least two different laboratories. In addition, nine antiserum reagents were subjected in the lyophilized state to accelerated thermal degradation tests. The overall picture of the results obtained with the GI test was that of a remarkable degree of agreement among observations made in the different laboratories and with those originally reported by the Collaborating Centre. Results obtained with the MI test generally showed greater variation from one laboratory to another and, to some extent, on repeated testing of a serum in the same laboratory. From the combined results of the two tests the potencies of nine antisera were considered to be below acceptable levels for reference reagents. The potency of the remaining 20 antisera ranged from satisfactory to very high levels. Additionally these sera proved highly specific in both tests. The results of the thermal degradation tests carried out on about one-third of the serum reagents showed the stability of these reagents to be very satisfactory and to satisfy international requirements. It was concluded that although the antisera tested could not be established as standard reference reagents they should be regarded as working reagents. In this capacity they have already proved extremely useful in a great many mycoplasma laboratories all over the world.
Publication Date: 1983-07-01 PubMed ID: 6885829DOI: 10.1016/s0092-1157(83)80010-9Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research focused on testing the potency and specificity of 29 Mycoplasma and Acholeplasma antiserum reagents, produced for the study of mycoplasmas in animals. While the antiserum reagents were not suitable for use as standard reference tools, they proved to be effective for practical use in many mycoplasma laboratories worldwide.

Objective of the Research

  • The goal of the research was to test the potency and specificity of 29 Mycoplasma and Acholeplasma antiserum reagents. These reagents were produced in mules and horses by biology laboratories in the US and UK, under the sponsorship of the National Institutes of Health.

Methodology

  • The antiserum reagents were first tested at the University of Aarhus in Denmark using a variety of serological techniques.
  • The reagents were then further tested in a collaborative assay by 20 participants from 15 different laboratories under the International Research Programme on Comparative Mycoplasmology. Homologous and heterologous reactivity of the reagents was tested using growth inhibition (GI) and metabolism inhibition (MI) tests.
  • Nine of the antiserum reagents were also subjected to accelerated thermal degradation tests to assess their stability.

Findings

  • The tests showed a significant degree of agreement among different laboratories, especially with regards to the GI test results.
  • The MI test results showed more variation across different laboratories and also in repeated tests within the same laboratory.
  • Only nine out of the 29 antisera proved potent enough to serve as reference reagents, with the remaining 20 shadows showing satisfactory to very high levels of potency.
  • The reagents that passed the tests showed high levels of specificity and stability, adhering to international standards.
  • Despite their insufficiency to act as standard reference reagents, these antiserums functioned effectively as working reagents in numerous mycoplasma labs, confirming their practical utility.

Cite This Article

APA
Freundt EA. (1983). A collaborative assay of mycoplasma reference antisera. J Biol Stand, 11(3), 227-240. https://doi.org/10.1016/s0092-1157(83)80010-9

Publication

ISSN: 0092-1157
NlmUniqueID: 0400335
Country: England
Language: English
Volume: 11
Issue: 3
Pages: 227-240

Researcher Affiliations

Freundt, E A

    MeSH Terms

    • Animals
    • Antibody Specificity
    • Guinea Pigs
    • Hot Temperature
    • Humans
    • Immune Sera / immunology
    • Immune Sera / standards
    • Mycoplasma / immunology
    • Mycoplasma / metabolism

    Citations

    This article has been cited 3 times.
    1. Hallamaa KM, Tang SL, Ficorilli N, Browning GF. Differential expression of lipoprotein genes in Mycoplasma pneumoniae after contact with human lung epithelial cells, and under oxidative and acidic stress. BMC Microbiol 2008 Jul 23;8:124.
      doi: 10.1186/1471-2180-8-124pubmed: 18647421google scholar: lookup
    2. Barile MF, Chandler DK, Yoshida H, Grabowski MW, Razin S. Hamster challenge potency assay for evaluation of Mycoplasma pneumoniae vaccines. Infect Immun 1988 Sep;56(9):2450-7.
    3. Olson LD, Shane SW, Karpas AA, Cunningham TM, Probst PS, Barile MF. Monoclonal antibodies to surface antigens of a pathogenic Mycoplasma hominis strain. Infect Immun 1991 May;59(5):1683-9.